Scarica l'app Stockscreener
8.93
1.36%
0.12
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RLAY Giù?
Forum
Previsione
Relay Therapeutics Inc Borsa (RLAY) Ultime notizie
Will Relay Therapeutics Inc. benefit from government policy2025 Price Targets & Free Community Supported Trade Ideas - mfd.ru
Can Relay Therapeutics Inc. expand its profit marginsPortfolio Update Report & Weekly Watchlist of Top Performers - mfd.ru
Can Relay Therapeutics Inc. sustain its profitability2025 Bull vs Bear & Low Risk High Reward Trade Ideas - mfd.ru
Relay Therapeutics stock hits 52-week high at $9.16 By Investing.com - Investing.com South Africa
Relay Therapeutics (NASDAQ:RLAY) Sets New 12-Month HighTime to Buy? - MarketBeat
Relay Therapeutics stock hits 52-week high at $9.16 - Investing.com
Assessing Relay Therapeutics (RLAY) Valuation After Recent Share Price Momentum And Price To Book Discount - Sahm
Assessing Relay Therapeutics (RLAY) Valuation After FDA Breakthrough Therapy Designation For Zovegalisib - Yahoo Finance
Relay Therapeutics Insider Sells 21,000 Shares for $166,700 After 65% Run - The Globe and Mail
$207B Market Shift: The Race for Fast Track Approval in Oncology - Investing News Network
$207B Market Shift: The Race for Fast Track Approval in Oncology - Benzinga
Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026 - Investing News Network
Relay Thera’s zovegalisib wins ‘Breakthrough’ status from FDA - The Pharma Letter
Relay Therapeutics announces Zovegalisib granted therapy designation by FDA for PIK3CA-mutant - marketscreener.com
Relay Therapeutics stock rises after FDA grants Breakthrough Therapy status By Investing.com - Investing.com South Africa
Relay Therapeutics stock rises after FDA grants Breakthrough Therapy status - Investing.com
Relay Therapeutics Announces Breakthrough Therapy Designation for Zovegalisib - TradingView
Relay Therapeutics Announces Zovegalisib Granted - GlobeNewswire
Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer - The Manila Times
Aug Retail: Can Relay Therapeutics Inc sustain its profitabilityProfit Target & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Oppenheimer Notes Relay Therapeutics, Inc. (RLAY) Pipeline Strength in Mutant-Selective Inhibitors - Finviz
Relay Therapeutics (NASDAQ:RLAY) Shares Up 7.2%Here's Why - MarketBeat
Oppenheimer Notes Relay Therapeutics (RLAY) Pipeline Strength in Mutant-Selective Inhibitors - Yahoo Finance
Rate Cut: Is Relay Therapeutics Inc a speculative investmentPortfolio Gains Report & Consistent Profit Alerts - baoquankhu1.vn
Movement Recap: Will Relay Therapeutics Inc benefit from government policyWeekly Profit Recap & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring an 88.66% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Relay Therapeutics (RLAY) Valuation Check After Analyst Upgrades And Zovegalisib Breast Cancer Data - Sahm
Relay Therapeutics president sells $166k in RLAY stock By Investing.com - Investing.com Australia
Moving Averages: Is Trex Company Inc stock a buy or sellTrade Analysis Summary & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Guidance Update: Can Relay Therapeutics Inc reach all time highs this year - baoquankhu1.vn
Relay Therapeutics (NASDAQ:RLAY) Insider Donald Bergstrom Sells 2,686 Shares - MarketBeat
Relay Therapeutics (NASDAQ:RLAY) Insider Sells $11,441.30 in Stock - MarketBeat
Insider Selling: Relay Therapeutics (NASDAQ:RLAY) CFO Sells 1,695 Shares of Stock - MarketBeat
Insider Selling: Relay Therapeutics (NASDAQ:RLAY) Insider Sells 11,684 Shares of Stock - MarketBeat
Thomas Catinazzo Sells 13,820 Shares of Relay Therapeutics (NASDAQ:RLAY) Stock - MarketBeat
Rahmer Peter, chief corporate development officer at Relay Therapeutics, sells $100k in shares - Investing.com Canada
Relay Therapeutics president sells $166k in RLAY stock - Investing.com
Relay Therapeutics (NASDAQ:RLAY) Stock Price Down 6.7%Should You Sell? - MarketBeat
Trend Recap: What is the Moat Score of REGNJuly 2025 Setups & Technical Pattern Alert System - baoquankhu1.vn
Oppenheimer Upgrade Fuels Relay Therapeutics Rally On Zovegalisib Optimism (NASDAQ:RLAY) - Seeking Alpha
Relay Therapeutics shares climb after Oppenheimer lifts rating - MSN
Relay Therapeutics (NASDAQ:RLAY) Trading Up 8.4%Here's Why - MarketBeat
Oppenheimer Upgrades Relay Therapeutics (RLAY) with Positive Out - GuruFocus
Oppenheimer Upgrades Relay Therapeutics (RLAY) - Nasdaq
Oppenheimer upgrades Relay Therapeutics stock rating on gedatolisib concerns By Investing.com - Investing.com Canada
Relay Therapeutics (RLAY) Upgraded by Oppenheimer, Price Target Set at $14.00 | RLAY Stock News - GuruFocus
Relay Therapeutics stock rises after Oppenheimer upgrade By Investing.com - Investing.com Nigeria
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):